Post-marketing Clinical Trial of KAD-1229 in Patients With Type 2 Diabetes Mellitus

Clinical trial NCT02154347 · COMPLETED

Trial details

NCT number: NCT02154347
Sponsor: Kissei Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Primary completion: 2016-07-01
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.